Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-29
2008-01-29
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S575000
Reexamination Certificate
active
07323457
ABSTRACT:
Sulfonamide and urea compounds having an inhibitory effect on Src kinase including enantiomers, stereoisomers and tautomers thereof, as well as pharmaceutically acceptable salts or solvates of said compound, said compound having the general structure shown in Formula II are disclosed and claimed:
REFERENCES:
patent: 6362210 (2002-03-01), Hauel et al.
patent: 6500803 (2002-12-01), Klingler et al.
patent: 6727250 (2004-04-01), Hauel et al.
patent: WO 00/49018 (2000-08-01), None
B. Lawrence Riggs, et. al., Overview of Osteoporosis, West Journal Medicine (1991, pp. 63-77, vol. 154).
Fahad A. Al-Obeidi, et. al., Protein Tyrosine Kinases: Structure, Substrate Specificity, and Drug Discovery, Biopolymer Peptide Science (1998, pp. 197-223, vol. 47).
W. A. Peck, et. al., Consensus Development Conference: Diagnosis, Prophylaxis, and Treatment of Osteoporosis, The American Journal of Medicine (1993, pp. 646-650, vol. 94).
Safar Pavel
Shimshock Stephen James
Walser Armin
Aventis Pharmaceuticals Inc.
Coppins Janet L.
Gupta Balaram
Saeed Kamal
LandOfFree
Substituted sulfonamides and ureas useful for inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted sulfonamides and ureas useful for inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulfonamides and ureas useful for inhibiting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807216